AIDS policy and pharmaceutical patents: Brazil's strategy to safeguard public health

World Economy

Volumn 28, Issue 2, 2005, Pages 211-230

  Cohen, Jillian Clare ^a   Lybecker, Kristina M ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; PUBLIC HEALTH;

BRAZIL; SOUTH AMERICA; WESTERN HEMISPHERE; WORLD;

EID: 14744303657     PISSN: 03785920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-9701.2005.00668.x     Document Type: Article

References (32)

1. Allafrica.com (2003), 'Authority Licenses Two Drug Factories to Produce Anti-Retroviral Drugs', Addis Tribune (Addis Ababa), World Wide Web Posting, 18 April (http://allafrica.com/stories/200304180028.html).
2. Bermudez, J. (2002), 'Promoting Expansion of Access to Essential Medicines and Vaccines: Lessons Learnt in Brazil', Presentation at the 10th ICDRA 2002, Hong Kong (June, http://www.who.int/medicines/library/ qsm/icdra02/ppt/Jorge_Bermudez.ppt).
3. Brazilian Ministry of Health (2000a), 'The Brazilian National Drug Policy', Official Document (January).
4. Brazilian Ministry of Health (2000b), Jillian Clare Cohen, Interview with senior adviser in the Ministry of Health, Brasilia (January).
5. Brazilian Ministry of Health (2002), 'AIDS Drugs Policy', World Wide Web Posting (www.aids.gov.br/assistencia/aids_drugs_policy.htm).
6. Case, B. M. and L. Iliff (2003), 'Mexico Seeks Remedy for High Drug Costs: Proposal to Relax Protection on Patents Touches off Debate', The Dallas Morning News (9 April, http://www.kmsb.com/business/ news/040903dnbusmexicorx.a2a09.html).
7. Cohen, J. C. (2000), 'Public Policies in the Pharmaceutical Sector: A Case Study of Brazil', LCSHD Paper Series Number 54 (Washington, DC: The World Bank, January).
8. Galvao, J. (2002), 'Access to Antiretroviral Drugs in Brazil', The Lancet, 360 (7 December), 1862-65.
9. GlobalOptions, Inc. (2003), An Analysis of Terrorist Threats to America's Medicine Supply (Gaithersburg, Maryland: Signature Book Printing).
10. Health GAP Coalition (2001), 'Brazil's Threat to Break Roche Patent on Nelfinavir', World Wide Web Posting (22 August, http:// lists.essential.org/pipermail/pharm-policy/2001-August/001394.html).
11. IMS Health (2002), 'Market Report: Five Year Forecast of the Global Pharmaceutical Markets', World Wide Web Posting (www.ims-global.com/ insight/report/global/report.htm).
12. International Federation of Pharmaceutical Manufactures Association (IFPMA) (2002), 'The Reality Behind "The Brazilian Model"' (Geneva, Switzerland: IFPMA, 12 April).
13. Jordan, M. (2001), 'Brazil to Break Roche Patent on AIDS Drug', The Wall Street Journal (23 August), A3.
14. Lybecker, K. M. (2001), 'The Brazilian Pharmaceutical Industry: the TRIPS Agreement & Its Consequences', Paper prepared for the 2001 Latin American Studies Association Meetings (Washington, DC, September).
15. Lybecker, K. M. (2000), 'Product Piracy: The Sale of Counterfeit Pharmaceuticals in Developing Countries', Doctoral dissertation, Berkeley, California (Department of Economics, University of California, Berkeley, December).
16. Maletsky, C. (2003), 'Namibian Firm Will Produce AIDS Drugs, says Minister', BBC Monitoring International Reports via NewsEdge Corporation, World Wide Web Posting (10 June, http://www.namibian.com.na/ 2003/june/national/03D7C6D117.html).
17. Maskus, K. E. (2000), Intellectual Property Rights in the Global Economy (Washington, DC: Institute for International Economics, August).
18. Mendonca, T. (1999), 'The Pharmaceutical Industry', Industry Sector Analysis, Corporate Information (US Department of State, 1 February, http://www.corporateinformation.com/data/statusa/brazil/ pharmaceuticals.html).
19. Pharmaceutical Research and Manufacturers of America (PhRMA) (2003), 'WHO to Adopt Brazilian Model to Fight AIDS/HIV', BBC Monitoring International Reports via NewsEdge Corporation, World Wide Web Posting (21 May).
20. Rich, J. L. with M. Petersen (2001), 'Brazil Will Defy Patent on HIV/ AIDS Drug Made By Roche', The New York Times, World Wide Web Posting (23 August, http://www.nytimes.com/2001/08/23/business/ 23DRUG.html).
21. Scherer, F. M. and J. Watal (2001), 'Post-TRIPS Options for Access to Patented Medicines in Developing Countries', CMH Working Paper Series, World Health Organisation, Commission on Macroeconomics and Health (Geneva, Switzerland: World Health Organisation, June).
22. SCRIP (1999a), World Pharmaceutical News, No. 1410 (10 February).
23. SCRIP (1999b), World Pharmaceutical News, No. 2409 (5 February), 17.
24. Shen, R. (2003), 'Boehringer Ingelheim will Respect Compulsory Licenses', posting to IP-Health mailing list, ip-healthλists.essential.org, IP-Health digest, 1, 1191, message 3 (1 July).
25. Sykes, A. O. (2002), 'TRIPS, Pharmaceuticals, Developing Countries, and the Doha "Solution"', John M. Olin Law & Economics Working Paper No. 140 (The Chicago Working Paper Series, University of Chicago Law School, Chicago, Illinois, January).
26. Szwarcwald, C. L. (2002), 'The Impact of National Production of ARV Drugs on the Cost of the ARV Therapy in Brazil, 1997-2000', Oral Presentation at the XIV International AIDS Conference (Barcelona, Spain, 7-12 July, www.aids2002.com).
27. Watal, J. (2000), 'Pharmaceutical Patents, Prices and Welfare Losses: Policy Options for India Under the WTO TRIPS Agreement', The World Economy, 23, 5, 733-52.
28. World Bank, Brazil Country Management Unit (1999), 'Brazil Health Sector Strategy', internal document (Washington, DC: World Bank).
29. World Bank, Operations Evaluation Department (1998), 'Brazil: The Brazil Health System -Impact Evaluation Report', Report No. 18142 (Washington, DC: World Bank, 30 June).
30. World Health Organisation, Drug Action Program (1998), 'Pharmaceuticals and Health Sector Reform in the Americas: An Economic Perspective' (Geneva, Switzerland: WHO).
31. World Trade Organisation, OMC (2001a), 'TRIPS and Pharmaceutical Patents', WTO OMC, Fact Sheet (April, http://www.wto.org/wto/english/ tratop_e/TRIPS_e/factsheet_pharm00_e.htm).
32. World Trade Organisation (2001b), 'TRIPS: Council Discussion on Access to Medicine - Developing Country Group's Paper', IP/C/W/296 (World Trade Organisation, 19 June, http://www.wto.org/English/tratop_e/trips_e/ paper_develop_w296_e.htm).